Titel

Merkliste
1 Ergebnisse

Evaluation of dose‐dependent treatment effects after mid‐tr..:

Wang, Guoqiao ; Li, Yan ; Xiong, Chengjie...
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring. 14 (2022) 1 - p. , 2022

Link: https://doi.org/10.1002/dad2.12367

RT Journal
T1 <Title>Evaluation of dose‐dependent treatment effects after mid‐trial dose escalation in biomarker, clinical, and cognitive outcomes for gantenerumab or solanezumab in dominantly inherited Alzheimer's disease</Title>

UL https://suche.suub.uni-bremen.de/peid=cr-10.1002_dad2.12367&Exemplar=1&LAN=DE
				
A1 Wang, Guoqiao
A1 Li, Yan
A1 Xiong, Chengjie
A1 McDade, Eric
A1 Clifford, David B.
A1 Mills, Susan L.
A1 Santacruz, Anna M.
A1 Aschenbrenner, Andrew J.
A1 Hassenstab, Jason
A1 Benzinger, Tammie L.S.
A1 Gordon, Brian A.
A1 Fagan, Anne M.
A1 Coalier, Kelley A.
A1 Libre‐Guerra, Jorge J.
A1 McCullough, Austin
A1 Joseph‐Mathurin, Nelly
A1 Chen, Charles D.
A1 Mummery, Catherine
A1 Wendelberger, Barbara A.
A1 Gauthier, Serge
A1 Masellis, Mario
A1 Holdridge, Karen C.
A1 Yaari, Roy
A1 Chatterjee, Saptarshi
A1 Sims, John
A1 Delmar, Paul
A1 Kerchner, Geoffrey A.
A1 Bittner, Tobias
A1 Hofmann, Carsten
A1 Bateman, Randall J.
PB Wiley
YR 2022
SN 2352-8729
SN 2352-8729
JF Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
VO 14
IS 1
LK http://dx.doi.org/https://doi.org/10.1002/dad2.12367
DO https://doi.org/10.1002/dad2.12367
SF ELIB - SuUB Bremen

Export

RefWorks (nur Desktop-Version!)
Flow (Zuerst in Flow einloggen, dann importieren)